2024. Comparison of Efficacy of Intravenous Amikacin with Intravenous Cefoparazone/Sulbactum in Urinary Tract Infections Caused by Escherichia Coli Indiabetic Patients. Medical Forum Monthly. 30, 8 (May 2024).